WO2024091652A1 - Procédés de préparation de compositions de poudre revêtues - Google Patents
Procédés de préparation de compositions de poudre revêtues Download PDFInfo
- Publication number
- WO2024091652A1 WO2024091652A1 PCT/US2023/036104 US2023036104W WO2024091652A1 WO 2024091652 A1 WO2024091652 A1 WO 2024091652A1 US 2023036104 W US2023036104 W US 2023036104W WO 2024091652 A1 WO2024091652 A1 WO 2024091652A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- powder particles
- pulses
- seconds
- inches
- processing region
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 315
- 238000000034 method Methods 0.000 title claims abstract description 157
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 230000008569 process Effects 0.000 title claims description 93
- 239000002245 particle Substances 0.000 claims abstract description 351
- 238000000576 coating method Methods 0.000 claims abstract description 191
- 238000012545 processing Methods 0.000 claims abstract description 168
- 230000008021 deposition Effects 0.000 claims abstract description 124
- 229910044991 metal oxide Inorganic materials 0.000 claims abstract description 117
- 150000004706 metal oxides Chemical class 0.000 claims abstract description 117
- 239000011248 coating agent Substances 0.000 claims abstract description 92
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 90
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 60
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000011787 zinc oxide Substances 0.000 claims abstract description 30
- 238000010926 purge Methods 0.000 claims description 213
- 239000002243 precursor Substances 0.000 claims description 211
- 239000007789 gas Substances 0.000 claims description 193
- 229910052751 metal Inorganic materials 0.000 claims description 175
- 239000002184 metal Substances 0.000 claims description 175
- 239000007800 oxidant agent Substances 0.000 claims description 127
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 33
- 150000003839 salts Chemical class 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 claims description 9
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 claims description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 5
- 229910052786 argon Inorganic materials 0.000 claims description 5
- 239000012298 atmosphere Substances 0.000 claims description 5
- QQTGJVBUIOTPGZ-UHFFFAOYSA-N CCC[Zn]CCC Chemical compound CCC[Zn]CCC QQTGJVBUIOTPGZ-UHFFFAOYSA-N 0.000 claims description 4
- KBLZFQBDODEHJH-UHFFFAOYSA-N dibutylalumane Chemical compound C(CCC)[AlH]CCCC KBLZFQBDODEHJH-UHFFFAOYSA-N 0.000 claims description 4
- HJXBDPDUCXORKZ-UHFFFAOYSA-N diethylalumane Chemical compound CC[AlH]CC HJXBDPDUCXORKZ-UHFFFAOYSA-N 0.000 claims description 4
- TUTOKIOKAWTABR-UHFFFAOYSA-N dimethylalumane Chemical compound C[AlH]C TUTOKIOKAWTABR-UHFFFAOYSA-N 0.000 claims description 4
- AXAZMDOAUQTMOW-UHFFFAOYSA-N dimethylzinc Chemical compound C[Zn]C AXAZMDOAUQTMOW-UHFFFAOYSA-N 0.000 claims description 4
- XOCWTYIVWYOSGQ-UHFFFAOYSA-N dipropylalumane Chemical compound C(CC)[AlH]CCC XOCWTYIVWYOSGQ-UHFFFAOYSA-N 0.000 claims description 4
- SQBBHCOIQXKPHL-UHFFFAOYSA-N tributylalumane Chemical compound CCCC[Al](CCCC)CCCC SQBBHCOIQXKPHL-UHFFFAOYSA-N 0.000 claims description 4
- VOITXYVAKOUIBA-UHFFFAOYSA-N triethylaluminium Chemical compound CC[Al](CC)CC VOITXYVAKOUIBA-UHFFFAOYSA-N 0.000 claims description 4
- CNWZYDSEVLFSMS-UHFFFAOYSA-N tripropylalumane Chemical compound CCC[Al](CCC)CCC CNWZYDSEVLFSMS-UHFFFAOYSA-N 0.000 claims description 4
- HEPBQSXQJMTVFI-UHFFFAOYSA-N zinc;butane Chemical compound [Zn+2].CCC[CH2-].CCC[CH2-] HEPBQSXQJMTVFI-UHFFFAOYSA-N 0.000 claims description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 150000002978 peroxides Chemical class 0.000 claims description 3
- JAONJTDQXUSBGG-UHFFFAOYSA-N dialuminum;dizinc;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Zn+2].[Zn+2] JAONJTDQXUSBGG-UHFFFAOYSA-N 0.000 abstract description 19
- 229910010272 inorganic material Inorganic materials 0.000 abstract description 18
- 239000011147 inorganic material Substances 0.000 abstract description 16
- 239000011368 organic material Substances 0.000 abstract description 16
- 238000000151 deposition Methods 0.000 description 117
- 239000010410 layer Substances 0.000 description 45
- 229910052782 aluminium Inorganic materials 0.000 description 20
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 20
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 19
- 229910052725 zinc Inorganic materials 0.000 description 19
- 239000011701 zinc Substances 0.000 description 19
- 239000000126 substance Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000000546 pharmaceutical excipient Substances 0.000 description 11
- 239000003708 ampul Substances 0.000 description 10
- 238000000231 atomic layer deposition Methods 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 6
- 239000012159 carrier gas Substances 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000003877 atomic layer epitaxy Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000005137 deposition process Methods 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004590 computer program Methods 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- -1 carboxymethylethyl Chemical group 0.000 description 3
- 238000005229 chemical vapour deposition Methods 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 150000004767 nitrides Chemical class 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229910052814 silicon oxide Inorganic materials 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229960000913 crospovidone Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- AJNVQOSZGJRYEI-UHFFFAOYSA-N digallium;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Ga+3].[Ga+3] AJNVQOSZGJRYEI-UHFFFAOYSA-N 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 229910001195 gallium oxide Inorganic materials 0.000 description 2
- 238000011194 good manufacturing practice Methods 0.000 description 2
- 229910000449 hafnium oxide Inorganic materials 0.000 description 2
- WIHZLLGSGQNAGK-UHFFFAOYSA-N hafnium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Hf+4] WIHZLLGSGQNAGK-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000012792 lyophilization process Methods 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229910000484 niobium oxide Inorganic materials 0.000 description 2
- URLJKFSTXLNXLG-UHFFFAOYSA-N niobium(5+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Nb+5].[Nb+5] URLJKFSTXLNXLG-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 229910001936 tantalum oxide Inorganic materials 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000005019 vapor deposition process Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 240000004181 Eucalyptus cladocalyx Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000003798 L01XE11 - Pazopanib Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Chemical class 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001279 adipic acids Chemical class 0.000 description 1
- 239000003741 agents affecting lipid metabolism Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229920000615 alginic acid Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000578 anorexic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940125708 antidiabetic agent Drugs 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000003926 antimycobacterial agent Substances 0.000 description 1
- 229940034014 antimycobacterial agent Drugs 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003200 antithyroid agent Substances 0.000 description 1
- 229940043671 antithyroid preparations Drugs 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 239000002948 appetite stimulant Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 239000003633 blood substitute Substances 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- OCHFNTLZOZPXFE-JEDNCBNOSA-N carbonic acid;(2s)-2,6-diaminohexanoic acid Chemical compound OC(O)=O.NCCCC[C@H](N)C(O)=O OCHFNTLZOZPXFE-JEDNCBNOSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- RRPFCKLVOUENJB-UHFFFAOYSA-L disodium;2-aminoacetic acid;carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O.NCC(O)=O RRPFCKLVOUENJB-UHFFFAOYSA-L 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000003291 dopaminomimetic effect Effects 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 150000002238 fumaric acids Chemical class 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 239000000677 immunologic agent Substances 0.000 description 1
- 229940124541 immunological agent Drugs 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000004041 inotropic agent Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229960001021 lactose monohydrate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000002052 molecular layer Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 239000003149 muscarinic antagonist Substances 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- AHJRHEGDXFFMBM-UHFFFAOYSA-N palbociclib Chemical compound N1=C2N(C3CCCC3)C(=O)C(C(=O)C)=C(C)C2=CN=C1NC(N=C1)=CC=C1N1CCNCC1 AHJRHEGDXFFMBM-UHFFFAOYSA-N 0.000 description 1
- 229960004390 palbociclib Drugs 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000001499 parasympathomimetic effect Effects 0.000 description 1
- 230000000849 parathyroid Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- CUIHSIWYWATEQL-UHFFFAOYSA-N pazopanib Chemical compound C1=CC2=C(C)N(C)N=C2C=C1N(C)C(N=1)=CC=NC=1NC1=CC=C(C)C(S(N)(=O)=O)=C1 CUIHSIWYWATEQL-UHFFFAOYSA-N 0.000 description 1
- 229960000639 pazopanib Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- ABVRVIZBZKUTMK-JSYANWSFSA-M potassium clavulanate Chemical compound [K+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 ABVRVIZBZKUTMK-JSYANWSFSA-M 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- ILJOYZVVZZFIKA-UHFFFAOYSA-M sodium;1,1-dioxo-1,2-benzothiazol-3-olate;hydrate Chemical compound O.[Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 ILJOYZVVZZFIKA-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 150000003444 succinic acids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001975 sympathomimetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000005341 toughened glass Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
- C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
- C23C16/4417—Methods specially adapted for coating powder
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
- C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
- C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
- C23C16/40—Oxides
- C23C16/403—Oxides of aluminium, magnesium or beryllium
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
- C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
- C23C16/455—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for introducing gases into reaction chamber or for modifying gas flows in reaction chamber
- C23C16/45523—Pulsed gas flow or change of composition over time
- C23C16/45525—Atomic layer deposition [ALD]
- C23C16/45555—Atomic layer deposition [ALD] applied in non-semiconductor technology
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B25/00—Single-crystal growth by chemical reaction of reactive gases, e.g. chemical vapour-deposition growth
- C30B25/02—Epitaxial-layer growth
Definitions
- Embodiments of the present disclosure generally relate to coating processes, and more specifically, vapor coating processes for preparing coated particles.
- Atomic layer epitaxy (ALE) and atomic layer deposition (ALD) are a selflimiting processes, each utilize alternated pulses of reactants to saturate a substrate surface and leave a monolayer of material per cycle.
- Each of the reactant pulses typically lasts in a range from a few milliseconds to several seconds.
- the deposition conditions and reactants are selected to ensure self-saturating reactions, such that an adsorbed layer in one pulse leaves a surface termination that is non-reactive with the gas phase reactants of the same pulse.
- a subsequent pulse of a different reactant reacts with the previous termination to enable continued deposition.
- each cycle of alternated pulses typically leaves about one molecular layer of the deposited material.
- ALE or ALD processes are typically deposited on substrates, such as semi-conductor or microelectronic substrates, which usually have relatively large flat wafer surfaces, such as a silicon wafer with a 200 mm or 300 mm diameter.
- substrates such as semi-conductor or microelectronic substrates, which usually have relatively large flat wafer surfaces, such as a silicon wafer with a 200 mm or 300 mm diameter.
- ALE and ALD processes are often conducted as a thermal reaction or a plasma reaction and at temperatures of greater than 50°C, such as 100°C to 500°C or even great temperatures.
- particles of organic materials often decompose if heated to temperatures generally used during an ALE or ALD process.
- Embodiments of the present disclosure generally relate to vapor coating processes for preparing coated powder compositions.
- the coated powder composition is prepared from powder particles can be or contain one or more organic materials (e.g., active pharmaceutical ingredients (APIs), pharmaceutically acceptable excipients (PAEs), and/or other organic compounds), one or more inorganic materials (e.g., metal oxide particles), or combinations thereof.
- the plurality of powder particles are coated with a metal oxide, such as aluminum oxide, zinc oxide, or aluminum zinc oxide.
- a method of forming, producing, or otherwise preparing a coated powder composition includes positioning a plurality of powder particles within a processing region of a processing chamber, wherein each of the powder particles can be or contain an organic material, and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process.
- the metal oxide coating contains aluminum oxide, zinc oxide, or aluminum zinc oxide.
- the cyclic vapor coating process includes one or more deposition cycles.
- Each of the deposition cycles includes introducing two or more pulses of a metal precursor into the processing region via a first mass flow control (MFC) valve, exposing the plurality of powder particles to the metal precursor, and infiltrating the plurality of powder particles with the metal precursor via spaces between the powder particles. Thereafter, each of the deposition cycles includes introducing two or more pulses of a purge gas into the processing region via a second MFC valve, and exposing the plurality of powder particles to the purge gas during a first purge process.
- MFC mass flow control
- each of the deposition cycles includes introducing two or more pulses of an oxidizing agent into the processing region via a third MFC valve, exposing the plurality of powder particles to the oxidizing agent, and infiltrating the plurality of powder particles with the oxidizing agent via spaces between the powder particles to produce the metal oxide coating disposed on outer surfaces of each of the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a second purge process.
- a method of forming, producing, or otherwise preparing a coated powder composition includes positioning a plurality of powder particles within a processing region of a processing chamber, wherein each of the powder particles can be or contain an inorganic material, and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process.
- the metal oxide coating contains aluminum oxide, zinc oxide, or aluminum zinc oxide.
- the cyclic vapor coating process includes one or more deposition cycles.
- Each of the deposition cycles includes introducing two or more pulses of a metal precursor into the processing region via a first MFC valve, exposing the plurality of powder particles to the metal precursor, and infiltrating the plurality of powder particles with the metal precursor via spaces between the powder particles. Thereafter, each of the deposition cycles includes introducing two or more pulses of a purge gas into the processing region via a second MFC valve, and exposing the plurality of powder particles to the purge gas during a first purge process.
- each of the deposition cycles includes introducing two or more pulses of an oxidizing agent into the processing region via a third MFC valve, exposing the plurality of powder particles to the oxidizing agent, and infiltrating the plurality of powder particles with the oxidizing agent via spaces between the powder particles to produce the metal oxide coating disposed on outer surfaces of each of the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a second purge process.
- a method of forming, producing, or otherwise preparing a coated powder composition includes positioning a plurality of powder particles within a processing region of a processing chamber, and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process.
- the metal oxide coating contains aluminum zinc oxide.
- the cyclic vapor coating process includes one or more deposition cycles, and each of the deposition cycles includes introducing two or more pulses of a first metal precursor into the processing region via a first MFC valve, exposing the plurality of powder particles to the first metal precursor, and infiltrating the plurality of powder particles with the first metal precursor via spaces between the powder particles.
- each of the deposition cycles includes introducing two or more pulses of a purge gas into the processing region via a second MFC valve, and exposing the plurality of powder particles to the purge gas during a first purge process.
- each of the deposition cycles includes introducing two or more pulses of an oxidizing agent into the processing region via a third MFC valve, exposing the plurality of powder particles to the oxidizing agent, and infiltrating the plurality of powder particles with the oxidizing agent via spaces between the powder particles to produce a first metal oxide layer disposed on outer surfaces of each of the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a second purge process.
- each of the deposition cycles includes introducing two or more pulses of a second metal precursor into the processing region via a fourth MFC valve, exposing the plurality of powder particles to the second metal precursor, and infiltrating the plurality of powder particles with the second metal precursor via spaces between the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas into the processing region via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a third purge process.
- each of the deposition cycles includes introducing two or more pulses of the oxidizing agent into the processing region via the third MFC valve, exposing the plurality of powder particles to the oxidizing agent, and infiltrating the plurality of powder particles with the oxidizing agent via spaces between the powder particles to produce a second metal oxide layer disposed on the first metal oxide layer disposed on the outer surfaces of each of the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a fourth purge process.
- the first and second metal precursors are different from each other.
- the metal oxide coating contains the first metal oxide layer and the second metal oxide layer.
- the first metal oxide layer contains aluminum oxide
- the second metal oxide layer contains zinc oxide, or alternatively, the first metal oxide layer contains zinc oxide, then the second metal oxide layer contains aluminum oxide.
- FIGS. 1A-1 B are flow charts depicting one or more cyclic vapor coating processes, as described and discussed in one or more embodiments herein.
- Figures 2A-2B are flow charts depicting other cyclic vapor coating processes, as described and discussed in one or more embodiments herein.
- Figures 3A-3C depict a deposition system which can be used to perform cyclic vapor coating processes, as described and discussed in one or more embodiments herein.
- Figure 3A depicts a schematic cross-sectional front view of the deposition system
- Figure 3B depicts a schematic side view of the deposition system shown in Figure 3A
- Figure 3C is a schematic cross-sectional side view of the deposition system shown in Figure 3A. The view of Figure 3C can be taken along line 3C-3C in Figure 3A.
- Embodiments of the present disclosure generally relate to vapor coating processes for preparing coated powder compositions.
- the coated powder composition is prepared from powder particles can be or contain one or more organic materials (e.g., active pharmaceutical ingredients (APIs), pharmaceutically acceptable excipients (PAEs), and/or other organic compounds), one or more inorganic materials (e.g., metal oxide particles), or combinations thereof.
- the plurality of powder particles are coated with a metal oxide, such as aluminum oxide, zinc oxide, or aluminum zinc oxide.
- a method of forming, producing, or otherwise preparing a coated powder composition includes positioning a plurality of powder particles within a processing region of a processing chamber or reactor and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process.
- Each of the powder particles can be or contain one or more organic materials, one or more inorganic materials, or any combination thereof.
- the metal oxide coating contains aluminum oxide, zinc oxide, or aluminum zinc oxide.
- FIGS 1A-1 B are flow charts depicting a cyclic vapor coating process 100, as described and discussed in one or more embodiments herein.
- each of the deposition cycles of the cyclic vapor coating process 100 includes operations 110a-140a, as depicted in Figure 1A.
- each of the deposition cycles of the cyclic vapor coating process 100 includes operations 110b-140b, as depicted in Figure 1 B.
- the cyclic vapor coating process 100 may include one, two, three, or more deposition cycles.
- Each of the deposition cycles of the cyclic vapor coating process 100 can be repeated to form, produce, or otherwise prepare the metal oxide coating having a desired thickness.
- a metal oxide coating containing aluminum oxide or zinc oxide can be prepared by the cyclic vapor coating process 100.
- the plurality of powder particles is exposed to two or more pulses of the metal precursor (in operation 110a), then the plurality of powder particles is exposed to two or more pulses of the purge gas (in operation 120a), then the plurality of powder particles is exposed to two or more pulses of the oxidizing agent (in operation 130a), and then the plurality of powder particles is exposed to two or more pulses of the purge gas (in operation 140a) during the cyclic vapor coating process 100.
- a metal precursor exposure process in operation 110b, during a metal precursor exposure process, two or more pulses of a metal precursor are introduced into the processing region of the processing chamber or reactor via a first mass flow control (MFC) valve.
- MFC mass flow control
- the plurality of powder particles are exposed to the metal precursor.
- the plurality of powder particles is infiltrated by the metal precursor via spaces disposed between the powder particles.
- operation 120b during a first purge process, two or more pulses of a purge gas are introduced into the processing region via a second MFC valve.
- the plurality of powder particles is exposed to the purge gas.
- the plurality of powder particles is infiltrated by the purge gas via spaces between the powder particles, and any gas remnants is removed by purge gas.
- the gas remnants may contain excess amounts of the metal precursor, the purge gas, and/or other gases within the processing region.
- operation 130b during an oxidizing agent exposure process, two or more pulses of an oxidizing agent are introduced into the processing region via a third MFC valve.
- the plurality of powder particles is exposed to the oxidizing agent.
- the plurality of powder particles are infiltrated by the oxidizing agent via spaces between the powder particles to produce the metal oxide coating disposed on outer surfaces of each of the powder particles.
- operation 140b during a second purge process, two or more pulses of the purge gas are introduced into the processing region via a second MFC valve.
- the plurality of powder particles is exposed to the purge gas.
- the plurality of powder particles is infiltrated by the purge gas via spaces between the powder particles, and any gas remnants is removed by purge gas.
- the gas remnants may contain excess amounts of the metal precursor, the oxidizing agent, the purge gas, one or more reaction by-products, and/or other gases within the processing region.
- the metal precursor contains an aluminum precursor and the metal oxide coating contains aluminum oxide. In other examples while conducting the cyclic vapor coating process 100, the metal precursor contains a zinc precursor and the metal oxide coating contains zinc oxide.
- FIGS 2A-2B are flow charts depicting a cyclic vapor coating process 200, as described and discussed in one or more embodiments herein.
- each of the deposition cycles of the cyclic vapor coating process 200 includes operations 210a-280a, as depicted in Figures 2A.
- each of the deposition cycles of the cyclic vapor coating process 200 includes operations 210b-280b, as depicted in Figures 2B.
- the cyclic vapor coating process 200 may include one, two, three, or more deposition cycles. Each of the deposition cycles of the cyclic vapor coating process 200 can be repeated to form, produce, or otherwise prepare the metal oxide coating having a desired thickness.
- a metal oxide coating containing aluminum zinc oxide can be prepared by the cyclic vapor coating process 200.
- the metal oxide coating contains at least one layer of aluminum oxide and at least one layer of zinc oxide forming the aluminum zinc oxide.
- the metal oxide coating contains sequential pairs of aluminum oxide layers and zinc oxide layers.
- the plurality of powder particles is exposed to two or more pulses of the first metal precursor (in operation 210a), then the plurality of powder particles is exposed to two or more pulses of the purge gas (in operation 220a), then the plurality of powder particles is exposed to two or more pulses of the oxidizing agent (in operation 230a), and then the plurality of powder particles is exposed to two or more pulses of the purge gas (in operation 240a) during the cyclic vapor coating process 200.
- the plurality of powder particles is exposed to two or more pulses of the second metal precursor (in operation 250a), then the plurality of powder particles is exposed to two or more pulses of the purge gas (in operation 260a), then the plurality of powder particles is exposed to two or more pulses of the oxidizing agent (in operation 270a), and then the plurality of powder particles is exposed to two or more pulses of the purge gas (in operation 280a) during the cyclic vapor coating process 200.
- a first metal precursor in operation 210b, during a first metal precursor exposure process, two or more pulses of a first metal precursor are introduced into the processing region of the processing chamber or reactor via a first MFC valve.
- the plurality of powder particles are exposed to the first metal precursor.
- the plurality of powder particles is infiltrated by the first metal precursor via spaces disposed between the powder particles.
- the first metal precursor is or contains an aluminum precursor at operation 210b
- the second metal precursor is or contains a zinc precursor at operation 250b.
- the first metal precursor is or contains a zinc precursor at operation 210b
- the second metal precursor is or contains an aluminum precursor at operation 250b.
- operation 220b during a first purge process, two or more pulses of a purge gas are introduced into the processing region via a second MFC valve.
- the plurality of powder particles is exposed to the purge gas.
- the plurality of powder particles is infiltrated by the purge gas via spaces between the powder particles, and any gas remnants is removed by purge gas.
- the gas remnants may contain excess amounts of the first metal precursor, the purge gas, and/or other gases within the processing region.
- operation 230b during a first oxidizing agent exposure process, two or more pulses of an oxidizing agent are introduced into the processing region via a third MFC valve.
- the plurality of powder particles is exposed to the oxidizing agent.
- the plurality of powder particles are infiltrated by the oxidizing agent via spaces between the powder particles to produce the first metal oxide layer disposed on outer surfaces of each of the powder particles.
- the first metal oxide layer is a portion of the metal oxide coating to be prepared by the cyclic vapor coating process 200.
- operation 240b during a second purge process, two or more pulses of the purge gas are introduced into the processing region via the second MFC valve.
- the plurality of powder particles is exposed to the purge gas.
- the plurality of powder particles is infiltrated by the purge gas via spaces between the powder particles, and any gas remnants is removed by purge gas.
- the gas remnants may contain excess amounts of the first metal precursor, the oxidizing agent, the purge gas, one or more reaction by-products, and/or other gases within the processing region.
- operation 250b during a second metal precursor exposure process, two or more pulses of a second metal precursor are introduced into the processing region of the processing chamber or reactor via a fourth MFC valve.
- the plurality of powder particles are exposed to the second metal precursor.
- the plurality of powder particles is infiltrated by the second metal precursor via spaces disposed between the powder particles.
- operation 260b during a third purge process, two or more pulses of the purge gas are introduced into the processing region via the second MFC valve.
- the plurality of powder particles is exposed to the purge gas.
- the plurality of powder particles is infiltrated by the purge gas via spaces between the powder particles, and any gas remnants is removed by purge gas.
- the gas remnants may contain excess amounts of the first metal precursor, the second metal precursor, the oxidizing agent, the purge gas, one or more reaction by-products, and/or other gases within the processing region.
- operation 270b during a second oxidizing agent exposure process, two or more pulses of the oxidizing agent are introduced into the processing region via the third MFC valve.
- the plurality of powder particles is exposed to the oxidizing agent.
- the plurality of powder particles are infiltrated by the oxidizing agent via spaces between the powder particles to produce the second metal oxide layer disposed on the first metal oxide layer disposed on outer surfaces of each of the powder particles.
- the first and second metal oxide layers form the metal oxide coating prepared by the cyclic vapor coating process 200.
- operation 280b during a fourth purge process, two or more pulses of the purge gas are introduced into the processing region via the second MFC valve.
- the plurality of powder particles is exposed to the purge gas.
- the plurality of powder particles is infiltrated by the purge gas via spaces between the powder particles, and any gas remnants is removed by purge gas.
- the gas remnants may contain excess amounts of the first metal precursor, the second metal precursor, the oxidizing agent, the purge gas, one or more reaction by-products, and/or other gases within the processing region.
- the first and second metal precursors are different from each other, such as an aluminum precursor and a zinc precursor.
- the first metal precursor is or contains an aluminum precursor and the first metal oxide layer contains aluminum oxide
- the second metal precursor is or contains a zinc precursor and the second metal oxide layer contains zinc oxide.
- the first metal precursor is or contains a zinc precursor and the first metal oxide layer contains zinc oxide
- the second metal precursor is or contains an aluminum precursor and the second metal oxide layer contains aluminum oxide.
- the powder particles, coated by the cyclic vapor coating processes 100, 200 to produce coated particles can be or contain one or more organic materials, one or more inorganic materials, or any combination thereof. In one or more embodiments, the powder particles contain one or more organic materials.
- the organic material contained in the powder particles can be or contain one or more drugs, one or more active pharmaceutical ingredients (APIs), one or more pharmaceutically acceptable excipients (PAEs), other type of organic compounds, or any combination thereof.
- a "drug” in its broadest sense includes all small molecule (e.g., non-biologic) APIs.
- Exemplary drugs and/or APIs can be or include an analgesic, an anesthetic, an anti-inflammatory agent, an anthelmintic, an anti- arrhythmic agent, an antiasthma agent, an antibiotic, an anticancer agent, an anticoagulant, an antidepressant, an antidiabetic agent, an antiepileptic, an antihistamine, an antitussive, an antihypertensive agent, an antimuscarinic agent, an antimycobacterial agent, an antineoplastic agent, an antioxidant agent, an antipyretic, an immunosuppressant, an immunostimulant, an antithyroid agent, an antiviral agent, an anxiolytic sedative, a hypnotic, a neuroleptic, an astringent, a bacteriostatic agent, a beta-adrenoceptor blocking agent, a blood product, a blood substitute, a bronchodilator, a buffering agent, a cardiac inotropic agent, a chemo
- Exemplary types of small molecule drugs can be or include acetaminophen, clarithromycin, azithromycin, ibuprofen, fluticasone propionate, salmeterol, pazopanib HCI, palbociclib, and amoxicillin potassium clavulanate, salts thereof, complexes thereof, or any combination thereof.
- Exemplary PAEs, diluents, and/or carriers can be or include surfactants, polymers, sugars, binding agents, filling agents, lubricating agents, sweeteners, flavoring agents, preservatives, buffers, diluents, wetting agents, disintegrants, effervescent agents, salts thereof, hydrates thereof, or any combination thereof.
- Exemplary surfactants and polymers can be or include polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), sodium lauryl sulfate, polyvinylalcohol, crospovidone, polyvinylpyrrolidone-polyvinylacrylate copolymer, cellulose derivatives, hydroxypropylmethyl cellulose, hydroxypropyl cellulose, carboxymethylethyl cellulose, hydroxypropyllmethyl cellulose phthalate, polyacrylates and polymethacrylates, urea, sugars, polyols, carbomer and their polymers, emulsifiers, sugar gum, starch, organic acids and their salts, vinyl pyrrolidone and vinyl acetate, salts thereof, esters thereof, or any combination thereof.
- PEG polyethylene glycol
- PVP polyvinylpyrrolidone
- PVP polyvinylpyrrolidone
- sodium lauryl sulfate polyvinylalcohol
- Exemplary binding agents can be or include cellulose, cross-linked polyvinylpyrrolidone, microcrystalline cellulose, salts thereof, or any combination thereof.
- Exemplary filling agents can be or include lactose monohydrate, lactose anhydrous, microcrystalline cellulose, starches, salts thereof, complexes thereof, or any combination thereof.
- Exemplary lubricating agents such as agents that act on the flowability of a powder to be compressed, can be or include colloidal silicon dioxide, talc, stearic acid, magnesium stearate, calcium stearate, silica gel, or any combination thereof.
- Exemplary sweeteners can be or include sucrose, xylitol, sodium saccharin, cyclamate, aspartame, and acesulfame K, other natural sweeteners, other artificial sweeteners, salts thereof, or any combination thereof.
- Exemplary preservatives can be or include potassium sorbate, methylparaben, propylparaben, benzoic acid, benzoates, parahydroxybenzoic acid, esters of parahydroxybenzoic acid (e.g., butylparaben), alcohols (ethyl alcohol or benzyl alcohol), phenolic chemicals (e.g., phenol), quarternary compounds (e.g., benzalkonium chloride), salts thereof, esters thereof, or any combination thereof.
- Exemplary diluents and/or pharmaceutically acceptable inert fillers can be or include microcrystalline cellulose, lactose, dibasic calcium phosphate, saccharides, salts thereof, or any combination thereof.
- Exemplary wetting agents can be or include com starch, potato starch, maize starch, modified starches, salts thereof, or any combination thereof.
- Exemplary disintegrants can be or include croscarmellose sodium, crospovidone, sodium starch glycolate, salts thereof, or any combination thereof.
- Exemplary effervescent agents and/or effervescent couples can be or include organic acids (e.g., citric, tartaric, malic, fumaric, adipic, succinic, and alginic acids, anhydrides, and/or acid salts), or a carbonate (e.g., sodium carbonate, potassium carbonate, magnesium carbonate, sodium glycine carbonate, L-lysine carbonate, and arginine carbonate) or bicarbonate (e.g., sodium bicarbonate or potassium bicarbonate), salts thereof, esters thereof, or any combination thereof.
- organic acids e.g., citric, tartaric, malic, fumaric, adipic, succinic, and alginic acids, anhydrides, and/or acid salts
- a carbonate e.g., sodium carbonate, potassium carbonate, magnesium carbonate, sodium glycine carbonate, L-lysine carbonate, and arginine carbonate
- bicarbonate e
- the powder particles contain one or more inorganic materials.
- the inorganic material contained in the powder particles can be or contain one or more metal oxides, one or more metal nitrides, silicon oxide, silicon nitride, or any combination thereof.
- the inorganic material contained in the powder particles can be or contain aluminum oxide, titanium dioxide, iron oxide, gallium oxide, magnesium oxide, zinc oxide, niobium oxide, hafnium oxide, tantalum oxide, lanthanum oxide, zirconium dioxide, silicon oxide, silicates thereof, nitrides thereof, or any combination thereof.
- the plurality of powder particles is produced from a spray dried process or a lyophilization process, regardless of containing one or more organic materials, one or more inorganic materials, or combinations thereof.
- Other techniques can be used to make, fabricate, or otherwise produce the plurality of powder particles.
- the plurality of powder particles can have an average particle size in a range from about 0.1 pm, about 0.2 pm, about 0.3 pm, about 0.5 pm, about 0.8 pm, about 1 pm, about 2 pm, about 3 pm, about 5 pm, about 8 pm, about 10 pm, about 12 pm, about 15 pm, about 18 pm, about 20 pm, about 25 pm, about 30 pm, or about 35 pm to about 40 pm, about 50 pm, about 60 pm, about 70 pm, about 80 pm, about 90 pm, about 100 pm, about 120 pm, about 150 pm, about 200 pm, about 300 pm, about 400 pm, about 500 pm, about 600 pm, about 700 pm, about 800 pm, about 900 pm, or about 1 ,000 pm.
- the plurality of powder particles can have an average particle size of about 0.1 pm to about 1 ,000 pm, about 0.1 pm to about 500 pm, about 0.1 pm to about 200 pm, about 0.1 pm to about 150 pm, about 0.1 pm to about 100 pm, about 0.1 pm to about 80 pm, about 0.1 pm to about 50 pm, about 0.1 pm to about 30 pm, about 0.1 pm to about 20 pm, about 0.1 pm to about 10 pm, about 0.1 pm to about 8 pm, about 0.1 pm to about 5 pm, about 0.1 pm to about 2 pm, about 0.1 pm to about 1 pm, about 0.1 pm to about 0.5 pm, about 1 pm to about 1 ,000 pm, about 1 pm to about 500 pm, about 1 pm to about 200 pm, about 1 pm to about 150 pm, about 1 pm to about 100 pm, about 1 pm to about 80 pm, about 1 pm to about 50 pm, about 1 pm to about 30 pm, about 1 pm to about 20 pm, about 1 pm to about 10 pm, about 1 pm to about 8 pm, about 1 pm to about 5 pm, about 0.1
- the plurality of powder particles can have an average particle size of about 0.1 pm to about 1 ,000 pm. In some examples, the plurality of powder particles can have an average particle size of about 1 pm to about 100 pm. In other examples, the plurality of powder particles can have an average particle size of about 1 pm to about 30 pm, or about 1 pm to about 10 pm.
- a plurality of powder particles can be coated by the cyclic vapor coating processes 100, 200 to form, produce, or otherwise prepare the coated powder composition.
- the cyclic vapor coating processes 100, 200 are stagnant flow vapor deposition processes which provide consistent and uniform metal oxide coatings on the powder particles.
- the method includes a mass flow controller (“MFC") calibrated to deliver a precise number of chemical moles to a pressure isolated vessel.
- MFC mass flow controller
- any of the MFCs can have an orifice sized (e.g., about 0.062 inches or greater) for delivery of the metal precursor (e.g., metal organic vapor) at room temperature (e.g., about 25°C or less) and thus at low vapor pressure (e.g., about 20 Torr or less).
- the orifices of the MFCs used for the oxidizing agent and the purge gas may also be sized at about 0.062 inches or greater.
- Some active pharmaceutical ingredients are prone to thermal decomposition and some high surface area substrates (e.g., powder particles) are prone to non-uniform coating during conventional deposition processes.
- the cyclic vapor coating processes 100, 200 with the stagnant flow and utilizing the MFCs described and discussed herein overcome these shortcomings and include metal organic vapor delivery at near room temperature by compensating for ampoule pressure drift and for increasing chamber pressure due to reaction byproduct evolution.
- Some embodiments enable dosing control and provide process verification for Good Manufacturing Practice ("GMP”) compliance.
- GMP Good Manufacturing Practice
- the chambers and/or reactors contains a processing region to contain the plurality of powder particles which is coated by the cyclic vapor coating process to form, produce, or otherwise prepare the coated powder composition.
- rotary reactors with drums, stationary reactors with paddles, and other types of chambers and reactors can be used to perform the cyclic vapor coating processes 100, 200 and are further disclosed in U.S. Pat. No. 11 ,674,223B2, and U.S. Pub. No. 20230128094A1 , which are incorporated by reference in their entirety.
- CVD chemical vapor deposition
- ALD atomic layer deposition
- the plurality of powder particles can be heated, cooled, or otherwise maintained at a temperature in a range from about 0°C, about 10°C, about 12°C, about 15°C, about 18°C or about 20°C to about 22°C, about 23°C, about 25°C, about 28°C, or about 30°C during the cyclic vapor coating processes 100, 200.
- the plurality of powder particles can be heated, cooled, or otherwise maintained at a temperature of about 0°C to about 30°C, about 0°C to about 25°C, about 10°C to about 25°C, about 15°C to about 25°C, about 18°C to about 25°C, about 20°C to about 25°C, about 22°C to about 25°C, about 0°C to about 20°C, about 10°C to about 20°C, about 15°C to about 20°C, or about 18°C to about 20°C during the cyclic vapor coating processes 100, 200.
- the processing region within the chamber or reactor can be adjusted or otherwise maintained a stagnate atmosphere at a pressure of less than 760 T orr when each pulse of the metal precursors (e.g., the first metal precursor or the second metal precursor), the oxidizing agent, and/or the purge gas is independently introduced into the processing region during the cyclic vapor coating processes 100, 200.
- the stagnate atmosphere of the processing region can be at a pressure from about 10 Torr, about 50 Torr, or about 100 Torr to about 200 Torr, about 500 Torr, or about 750 Torr. In one or more examples, the stagnate atmosphere of the processing region can be at a pressure from about 10 Torr to about 750 Torr.
- the metal precursor (or the first metal precursor or the second metal precursor) can be or contain one or more aluminum precursors used during the cyclic vapor coating processes 100, 200.
- Exemplary aluminum precursors can be or contain trimethyl aluminum, dimethyl aluminum hydride, triethyl aluminum, diethyl aluminum hydride, tripropyl aluminum, dipropyl aluminum hydride, tributyl aluminum, dibutyl aluminum hydride, isomers thereof, salts thereof, of any combination thereof.
- each pulse of the aluminum precursor is introduced into the processing region without a carrier gas.
- a carrier gas can accompany the aluminum precursor into the processing region.
- the aluminum precursor (or the first metal precursor or the second metal precursor) can be introduced into the processing region at a flow rate in a range from about 10 seem, about 20 seem, about 25 seem, or about 30 seem to about 40 seem, about 50 seem, about 80 seem, or about 100 seem.
- the aluminum precursor (or the first metal precursor or the second metal precursor) can be introduced into the processing region at a partial pressure of less than 2 Torr, such as in a range from about 0.001 Torr, about 0.01 Torr, about 0.1 Torr, or about 0.5 Torr to about 0.8 Torr, about 1 Torr, or about 1 .8 Torr.
- the aluminum precursor (or the first metal precursor or the second metal precursor) can be at a temperature of about -20°C to about 25°C, about -20°C to about 23°C, about -20°C to about 20°C, about -20°C to about 18°C, about 0°C to about 25°C, about 0°C to about 23°C, about 0°C to about 20°C, about 0°C to about 18°C, about 15°C to about 25°C, about 15°C to about 23°C, about 15°C to about 20°C, or about 15°C to about 18°C and at a pressure of about 0.01 Torr to about 20 Torr when being introduced into the MFC valve.
- the metal precursor (including the first metal precursor or the second metal precursor) can be or contain one or more zinc precursors during the cyclic vapor coating processes 100, 200.
- Exemplary zinc precursors can be or contain dimethyl zinc, diethyl zinc, dipropyl zinc, dibutyl zinc, isomers thereof, salts thereof, of any combination thereof.
- each pulse of the zinc precursor is introduced into the processing region without a carrier gas.
- a carrier gas can accompany the zinc precursor into the processing region.
- the zinc precursor (or the first metal precursor or the second metal precursor) can be introduced into the processing region at a flow rate in a range from about 10 seem, about 20 seem, about 25 seem, or about 30 seem to about 40 seem, about 50 seem, about 80 seem, or about 100 seem.
- the zinc precursor (or the first metal precursor or the second metal precursor) can be introduced into the processing region at a partial pressure of less than 2 Torr, such as in a range from about 0.001 Torr, about 0.01 Torr, about 0.1 Torr, or about 0.5 Torr to about 0.8 Torr, about 1 Torr, or about 1.8 Torr.
- the zinc precursor (or the first metal precursor or the second metal precursor) can be at a temperature of about -20°C to about 25°C, about -20°C to about 23°C, about -20°C to about 20°C, about -20°C to about 18°C, about 0°C to about 25°C, about 0°C to about 23°C, about 0°C to about 20°C, about 0°C to about 18°C, about 15°C to about 25°C, about 15°C to about 23°C, about 15°C to about 20°C, or about 15°C to about 18°C and at a pressure of about 0.01 Torr to about 20 Torr when being introduced into the MFC valve.
- the oxidizing agent can be or contain water, oxygen (O2), hydrogen peroxide, inorganic peroxide, ozone, atomic oxygen, oxygen plasma, or any combination thereof during the cyclic vapor coating processes 100, 200.
- each pulse of the oxidizing agent is introduced into the processing region without a carrier gas.
- a carrier gas can accompany the oxidizing agent into the processing region.
- the oxidizing agent e.g., water vapor
- the oxidizing agent can be introduced into the processing region at a partial pressure of less than 2 Torr, such as in a range from about 0.001 Torr, about 0.01 Torr, about 0.1 Torr, or about 0.5 Torr to about 0.8 Torr, about 1 Torr, or about 1 .8 Torr.
- the purge gas (including the first, second, third, and/or fourth purge gases) can be or contain argon, helium, nitrogen (N2), or any combination thereof during the cyclic vapor coating processes 100, 200.
- the purge gas can be introduced into the processing region at a flow rate in a range from about 10 seem, about 20 seem, about 50 seem, or about 80 seem to about 100 seem, about 200 seem, about 300 seem, or about 500 seem.
- each of the deposition cycles of during the cyclic vapor coating processes 100, 200 includes introducing a number of pulses of the metal precursor into the processing region during a metal precursor exposure process.
- the metal precursor can be the first metal precursor, the second metal precursor, the aluminum precursor, and/or the zinc precursor during the metal precursor exposure process.
- each of the deposition cycles includes introducing a number of pulses of the metal precursor in a range from 2, 3, 4, 5, 6, 7, 8, 9, 10, about 12, about 15, about 18, about 20, about 25, about 30 pulses to about 32, about 35, about 38, about 40, about 45, about 50, about 60, about 70, about 80, about 90, about 100, about 110, about 120 pulses, or more of the metal precursor into the processing region during the metal precursor exposure process.
- each of the deposition cycles includes introducing from 2 pulses to about 100 pulses, from 2 pulses to about 80 pulses, from 2 pulses to about 50 pulses, from 2 pulses to about 35 pulses, from 2 pulses to about 30 pulses, from 2 pulses to about 25 pulses, from 2 pulses to about 20 pulses, from 2 pulses to about 15 pulses, from 2 pulses to about 10 pulses, from 2 pulses to about 8 pulses, from 2 pulses to about 5 pulses, from 3 pulses to about 100 pulses, from 3 pulses to about 80 pulses, from 3 pulses to about 50 pulses, from 3 pulses to about 35 pulses, from 3 pulses to about 30 pulses, from 3 pulses to about 25 pulses, from 3 pulses to about 20 pulses, from 3 pulses to about 15 pulses, from 3 pulses to about 10 pulses, from 3 pulses to about 8 pulses, from 3 pulses to about 5 pulses, from 5 pulses to about 100 pulses, from 5 pulses to about 80 pulses, from 5 pulses to
- each of the deposition cycles includes introducing from 3 pulses of the metal precursor to about 100 pulses of each of the first metal precursor and/or the second metal precursor into the processing region during the metal precursor exposure process. In other examples, each of the deposition cycles includes introducing from 5 pulses of the metal precursor to about 50 pulses of each of the first metal precursor and/or the second metal precursor into the processing region during the metal precursor exposure process. In some examples, each of the deposition cycles includes introducing from 8 pulses of the metal precursor to about 25 pulses of each of the first metal precursor and/or the second metal precursor into the processing region during the metal precursor exposure process.
- each of the pulses of the metal precursor is introduced into the processing region for a period in a range from about 20 seconds, about 30 seconds, about 40 seconds, about 45 seconds, or about 50 seconds to about 60 seconds, about 70 seconds, about 75 seconds, about 80 seconds, about 90 seconds, about 100 seconds, about 120 seconds, or longer during the metal precursor exposure process.
- the each of the pulses of the metal precursor is introduced into the processing region for about 20 seconds to about 120 seconds, about 20 seconds to about 100 seconds, about 20 seconds to about 90 seconds, about 20 seconds to about 75 seconds, about 20 seconds to about 60 seconds, about 20 seconds to about 45 seconds, about 20 seconds to about 30 seconds, about 30 seconds to about 120 seconds, about 30 seconds to about 100 seconds, about 30 seconds to about 90 seconds, about 30 seconds to about 75 seconds, about 30 seconds to about 60 seconds, about 30 seconds to about 45 seconds, about 40 seconds to about 120 seconds, about 40 seconds to about 100 seconds, about 40 seconds to about 90 seconds, about 40 seconds to about 75 seconds, about 40 seconds to about 60 seconds, about 60 seconds to about 120 seconds, about 60 seconds to about 100 seconds, about 60 seconds to about 90 seconds, or about 60 seconds to about 75 seconds during the metal precursor exposure process.
- a stagnant period In between the pulses of the metal precursor introduced into the processing region is a stagnant period when no metal precursor is introduced into the processing region.
- the metal precursor can infiltrate the plurality of powder particles and absorb to or react with the surfaces of the particles during the stagnant period.
- This stagnant period can range from about 20 seconds, about 30 seconds, about 40 seconds, about 45 seconds, or about 50 seconds to about 60 seconds, about 70 seconds, about 75 seconds, about 80 seconds, about 90 seconds, about 100 seconds, about 120 seconds, or longer between the pulses of the metal precursor during the metal precursor exposure process.
- the stagnant period can last for about 20 seconds to about 120 seconds, about 20 seconds to about 100 seconds, about 20 seconds to about 90 seconds, about 20 seconds to about 75 seconds, about 20 seconds to about 60 seconds, about 20 seconds to about 45 seconds, about 20 seconds to about 30 seconds, about 30 seconds to about 120 seconds, about 30 seconds to about 100 seconds, about 30 seconds to about 90 seconds, about 30 seconds to about 75 seconds, about 30 seconds to about 60 seconds, about 30 seconds to about 45 seconds, about 40 seconds to about 120 seconds, about 40 seconds to about 100 seconds, about 40 seconds to about 90 seconds, about 40 seconds to about 75 seconds, about 40 seconds to about 60 seconds, about 60 seconds to about 120 seconds, about 60 seconds to about 100 seconds, about 60 seconds to about 90 seconds, or about 60 seconds to about 75 seconds.
- each of the deposition cycles includes introducing a number of pulses of the oxidizing agent into the processing region during an oxidizing agent exposure process.
- the oxidizing agent can be the first oxidizing agent and/or the second oxidizing agent during the oxidizing agent exposure process.
- each of the deposition cycles includes introducing a number of pulses of the oxidizing agent in a range from 2, 3, 4, 5, 6, 7, 8, 9, 10, about 12, about 15, about 18, about 20, about 25, about 30 pulses to about 32, about 35, about 38, about 40, about 45, about 50, about 60, about 70, about 80, about 90, about 100, about 110, about 120 pulses, or more of the oxidizing agent into the processing region during the oxidizing agent exposure process.
- each of the deposition cycles includes introducing from 2 pulses to about 100 pulses, from 2 pulses to about 80 pulses, from 2 pulses to about 50 pulses, from 2 pulses to about 35 pulses, from 2 pulses to about 30 pulses, from 2 pulses to about 25 pulses, from 2 pulses to about 20 pulses, from 2 pulses to about 15 pulses, from 2 pulses to about 10 pulses, from 2 pulses to about 8 pulses, from 2 pulses to about 5 pulses, from 3 pulses to about 100 pulses, from 3 pulses to about 80 pulses, from 3 pulses to about 50 pulses, from 3 pulses to about 35 pulses, from 3 pulses to about 30 pulses, from 3 pulses to about 25 pulses, from 3 pulses to about 20 pulses, from 3 pulses to about 15 pulses, from 3 pulses to about 10 pulses, from 3 pulses to about 8 pulses, from 3 pulses to about 5 pulses, from 5 pulses to about 100 pulses, from 5 pulses to about 80 pulses, from 5 pulses to
- each of the deposition cycles includes introducing from 3 pulses of the oxidizing agent to about 100 pulses of each of the first oxidizing agent and/or the second oxidizing agent into the processing region during the oxidizing agent exposure process. In other examples, each of the deposition cycles includes introducing from 5 pulses of the oxidizing agent to about 50 pulses of each of the first oxidizing agent and/or the second oxidizing agent into the processing region during the oxidizing agent exposure process. In some examples, each of the deposition cycles includes introducing from 8 pulses of the oxidizing agent to about 25 pulses of each of the first oxidizing agent and/or the second oxidizing agent into the processing region during the oxidizing agent exposure process.
- each of the pulses of the oxidizing agent is introduced into the processing region for a period in a range from about 20 seconds, about 30 seconds, about 40 seconds, about 45 seconds, or about 50 seconds to about 60 seconds, about 70 seconds, about 75 seconds, about 80 seconds, about 90 seconds, about 100 seconds, about 120 seconds, or longer during the oxidizing agent exposure process.
- the each of the pulses of the oxidizing agent is introduced into the processing region for about 20 seconds to about 120 seconds, about 20 seconds to about 100 seconds, about 20 seconds to about 90 seconds, about 20 seconds to about 75 seconds, about 20 seconds to about 60 seconds, about 20 seconds to about 45 seconds, about 20 seconds to about 30 seconds, about 30 seconds to about 120 seconds, about 30 seconds to about 100 seconds, about 30 seconds to about 90 seconds, about 30 seconds to about 75 seconds, about 30 seconds to about 60 seconds, about 30 seconds to about 45 seconds, about 40 seconds to about 120 seconds, about 40 seconds to about 100 seconds, about 40 seconds to about 90 seconds, about 40 seconds to about 75 seconds, about 40 seconds to about 60 seconds, about 60 seconds to about 120 seconds, about 60 seconds to about 100 seconds, about 60 seconds to about 90 seconds, or about 60 seconds to about 75 seconds during the oxidizing agent exposure process.
- a stagnant period In between the pulses of the oxidizing agent introduced into the processing region is a stagnant period when no oxidizing agent is introduced into the processing region.
- the oxidizing agent can infiltrate the plurality of powder particles and absorb to or react with the surfaces of the particles during the stagnant period.
- This stagnant period can range from about 20 seconds, about 30 seconds, about 40 seconds, about 45 seconds, or about 50 seconds to about 60 seconds, about 70 seconds, about 75 seconds, about 80 seconds, about 90 seconds, about 100 seconds, about 120 seconds, or longer during the oxidizing agent exposure process.
- the stagnant period can last for about 20 seconds to about 120 seconds, about 20 seconds to about 100 seconds, about 20 seconds to about 90 seconds, about 20 seconds to about 75 seconds, about 20 seconds to about 60 seconds, about 20 seconds to about 45 seconds, about 20 seconds to about 30 seconds, about 30 seconds to about 120 seconds, about 30 seconds to about 100 seconds, about 30 seconds to about 90 seconds, about 30 seconds to about 75 seconds, about 30 seconds to about 60 seconds, about 30 seconds to about 45 seconds, about 40 seconds to about 120 seconds, about 40 seconds to about 100 seconds, about 40 seconds to about 90 seconds, about 40 seconds to about 75 seconds, about 40 seconds to about 60 seconds, about 60 seconds to about 120 seconds, about 60 seconds to about 100 seconds, about 60 seconds to about 90 seconds, or about 60 seconds to about 75 seconds.
- each of the deposition cycles includes introducing a number of pulses of the purge gas into the processing region, where the purge gas can independently be the first purge gas, the second purge gas, the third purge gas, and/or the fourth purge gas during a purge process.
- each of the deposition cycles includes introducing a number of pulses of the purge gas in a range from 2, 3, 4, 5, 6, 7, 8, 9, 10, about 12, about 15, about 18, about 20, about 25, about 30 pulses to about 32, about 35, about 38, about 40, about 45, about 50, about 60, about 70, about 80, about 90, about 100, about 110, about 120 pulses, or more of the purge gas into the processing region during the purge process.
- each of the deposition cycles includes introducing from 2 pulses to about 100 pulses, from 2 pulses to about 80 pulses, from 2 pulses to about 50 pulses, from 2 pulses to about 35 pulses, from 2 pulses to about 30 pulses, from 2 pulses to about 25 pulses, from 2 pulses to about 20 pulses, from 2 pulses to about 15 pulses, from 2 pulses to about 10 pulses, from 2 pulses to about 8 pulses, from 2 pulses to about 5 pulses, from 3 pulses to about 100 pulses, from 3 pulses to about 80 pulses, from 3 pulses to about 50 pulses, from 3 pulses to about 35 pulses, from 3 pulses to about 30 pulses, from 3 pulses to about 25 pulses, from 3 pulses to about 20 pulses, from 3 pulses to about 15 pulses, from 3 pulses to about 10 pulses, from 3 pulses to about 8 pulses, from 3 pulses to about 5 pulses, from 5 pulses to about 100 pulses, from 5 pulses to about 80 pulses, from 5 pulses to
- each of the deposition cycles includes independently introducing from 3 pulses of the purge gas to about 100 pulses of each of the first purge gas, the second purge gas, the third purge gas, and/or the fourth purge gas into the processing region during the purge process. In other examples, each of the deposition cycles includes introducing from 5 pulses of the purge gas to about 50 pulses of each of the first purge gas, the second purge gas, the third purge gas, and/or the fourth purge gas into the processing region during the purge process.
- each of the deposition cycles includes introducing from 8 pulses of the purge gas to about 25 pulses of each of the first purge gas, the second purge gas, the third purge gas, and/or the fourth purge gas into the processing region during the purge process.
- each of the pulses of the purge gas is introduced into the processing region for a period in a range from about 20 seconds, about 30 seconds, about 40 seconds, about 45 seconds, or about 50 seconds to about 60 seconds, about 70 seconds, about 75 seconds, about 80 seconds, about 90 seconds, about 100 seconds, about 120 seconds, or longer during the purge process.
- the each of the pulses of the purge gas is introduced into the processing region for about 20 seconds to about 120 seconds, about 20 seconds to about 100 seconds, about 20 seconds to about 90 seconds, about 20 seconds to about 75 seconds, about 20 seconds to about 60 seconds, about 20 seconds to about 45 seconds, about 20 seconds to about 30 seconds, about 30 seconds to about 120 seconds, about 30 seconds to about 100 seconds, about 30 seconds to about 90 seconds, about 30 seconds to about 75 seconds, about 30 seconds to about 60 seconds, about 30 seconds to about 45 seconds, about 40 seconds to about 120 seconds, about 40 seconds to about 100 seconds, about 40 seconds to about 90 seconds, about 40 seconds to about 75 seconds, about 40 seconds to about 60 seconds, about 60 seconds to about 120 seconds, about 60 seconds to about 100 seconds, about 60 seconds to about 90 seconds, or about 60 seconds to about 75 seconds during the purge process.
- a stagnant period In between the pulses of the purge gas introduced into the processing region is a stagnant period when no purge gas is introduced into the processing region.
- the purge gas can infiltrate the plurality of powder particles and flush or purge out remnant gases from the particles during the stagnant period.
- This stagnant period can range from about 20 seconds, about 30 seconds, about 40 seconds, about 45 seconds, or about 50 seconds to about 60 seconds, about 70 seconds, about 75 seconds, about 80 seconds, about 90 seconds, about 100 seconds, about 120 seconds, or longer during the purge process.
- the stagnant period can last for about 20 seconds to about 120 seconds, about 20 seconds to about 100 seconds, about 20 seconds to about 90 seconds, about 20 seconds to about 75 seconds, about 20 seconds to about 60 seconds, about 20 seconds to about 45 seconds, about 20 seconds to about 30 seconds, about 30 seconds to about 120 seconds, about 30 seconds to about 100 seconds, about 30 seconds to about 90 seconds, about 30 seconds to about 75 seconds, about 30 seconds to about 60 seconds, about 30 seconds to about 45 seconds, about 40 seconds to about 120 seconds, about 40 seconds to about 100 seconds, about 40 seconds to about 90 seconds, about 40 seconds to about 75 seconds, about 40 seconds to about 60 seconds, about 60 seconds to about 120 seconds, about 60 seconds to about 100 seconds, about 60 seconds to about 90 seconds, or about 60 seconds to about 75 seconds.
- the cyclic vapor coating process can include a variety of numbers of deposition cycles.
- the cyclic vapor coating process can include a number of deposition cycles in a range from 1 , 2, 3, 4, 5, 6, 7, or 8 to 9,10,
- the cyclic vapor coating process can include a number of deposition cycles from 1 to about 25, from 1 to about 20, from 1 to about 18, from 1 to about 15, from 1 to about 12, from 1 to about 10, from 1 to 9, from 1 to 8, from 1 to 7, from 1 to 6, from 1 to 5, from 1 to 4, from 1 to 3, from 1 to 2, from 2 to about 25, from 2 to about 20, from 2 to about 18, from 2 to about 15, from 2 to about 12, from 2 to about 10, from 2 to 9, from 2 to 8, from 2 to 7, from 2 to 6, from 2 to 5, from 2 to 4, from 2 to 3, from 3 to about 25, from 3 to about 20, from 3 to about 18, from 3 to about 15, from 3 to about 20, from 3 to about 18, from 3 to about 15, from 3 to about
- the deposition cycle is repeated from 2 times to about 20 times. In some examples, the deposition cycle is repeated from 3 times to about 10 times. In other examples, the deposition cycle is repeated from 4 times to about 8 times, or from 5 times to about 7 times.
- the size or diameter of the orifice for each of the MFC valves is independently selected for enhanced delivery of the respective gas, such as a precursor gas (e.g., metal precursor and oxidizing agent) or a purge gas during the cyclic vapor coating processes 100, 200.
- a precursor gas e.g., metal precursor and oxidizing agent
- a purge gas during the cyclic vapor coating processes 100, 200.
- Each of the first MFC valve, the second MFC valve, the third MFC valve, the fourth MFC valve, and any other MFC valve described and discussed herein, has a separate orifice for delivering the respective gas, such as a precursor gas (e.g., metal precursor and oxidizing agent) or a purge gas.
- Each of the orifices has a predetermined size or diameter to assist in providing the desired flow rate for the respective gas.
- Each of the orifices of the first MFC valve, the second MFC valve, the third MFC valve, the fourth MFC valve, and any other MFC valve described and discussed herein, independently has a diameter in a range from about 0.045 inches, about 0.048 inches, about 0.050 inches, about 0.052 inches, about 0.055 inches, about 0.058 inches, about 0.060 inches, about 0.062 inches, greater than 0.062 inches, about 0.065 inches, about 0.068 inches, about 0.070 inches, about 0.075 inches, or about 0.080 inches to about 0.08 5 inches, about 0.09I i inches, about 0.093 inches, about 0.095 inches, about 0.100 inches, about 0.105 inches, about 0.110 inches, about 0.111 inches, about 0.112 inches, about 0.113 inches, about 0.114 inches, about 0.115 inches, about 0.118 inches, about 0.120 inches, about 0.125 inches, about 0.130 inches, about 0.135 inches, about 0.140 inches, about 0.145 inches, about 0.150 inches, about 0.155 inches, about
- each of the orifices of the first MFC valve, the second MFC valve, the third MFC valve, the fourth MFC valve, and any other MFC valve described and discussed herein independently has a diameter of about 0.050 inches to about 0.150 inches, about 0.050 inches to about 0.140 inches, about 0.050 inches to about 0.130 inches, about 0.050 inches to about 0.125 inches, about 0.050 inches to about 0.120 inches, about 0.050 inches to about 0.118 inches, about 0.050 inches to about 0.115 inches, about 0.050 inches to about 0.113 inches, about 0.050 inches to about 0.110 inches, about 0.050 inches to about 0.108 inches, about 0.050 inches to about 0.105 inches, about 0.050 inches to about 0.100 inches, about 0.050 inches to about 0.095 inches, about 0.050 inches to about 0.090 inches, about 0.050 inches to about 0.080 inches, about 0.050 inches to about 0.075 inches, about 0.050 inches to about 0.070 inches, about 0.050 inches to about 0.060
- each of the orifices of the first MFC valve, the second MFC valve, the third MFC valve, and the fourth MFC valve independently has a diameter in a range from about 0.050 inches to about 0.150 inches. In some examples, each of the orifices of the first MFC valve, the second MFC valve, the third MFC valve, and the fourth MFC valve independently has a diameter in a range from about 0.062 inches to about 0.113 inches. In other examples, each of the orifices of the first MFC valve, the second MFC valve, the third MFC valve, and the fourth MFC valve independently has a diameter in a range from about 0.075 inches to about 0.105 inches.
- Figures 3A-3C illustrate a deposition system 300 for coating particles with a thin-film coating, as described and discussed in one or more embodiments herein.
- the deposition system 300 can be used to perform cyclic vapor coating processes 100, 200, and other cyclic vapor coating processes, such as a process to coat a plurality of powder particles with a metal oxide coating to form a plurality of coated particles.
- Figure 3A depicts a schematic cross-sectional front view of the deposition system 300 for performing cyclic vapor coating processes to coat particles.
- the deposition system 300 includes a rotary cylindrical reactor tube 410 (e.g., a rotary vacuum chamber).
- Figure 3B depicts a schematic side view of the deposition system 300 shown in Figure 3A.
- Figure 3C is a schematic cross-sectional side view of the deposition system 300 shown in Figure 3A. The view of Figure 3C can be taken along line 3C-3C in Figure 3A.
- the deposition system 300 includes reactor system 400 which has a rotary cylindrical reactor tube 410 (also referred to as a "drum") which can be partially filled with a plurality of powder particles 308 to form a particle bed within the processing region 414 of the reactor drum 410.
- a rotary cylindrical reactor tube 410 also referred to as a "drum”
- process gasses are injected into the drum through an inlet port and exhausted from the drum through an outlet port.
- the plurality of powder particles 308 in the drum undergo tumbling agitation so that the gasses can be applied uniformly to the particles and deposit a metal oxide layer or coating on the powder particles to produce the coated particles.
- the powder particles and/or the coated particles can have an average or median size (PSD D50) of about 0.5 pm to about 200 pm, about 2 pm to about 200 pm, or about 5 pm to about 100 pm.
- PSD D50 average or median size
- the deposition system 300 also include an isolator 310 that forms an isolated chamber 312. At least some components of the reactor system, including at least the reactor tube 410, are located in the chamber 312 of the isolator 310.
- the isolator 310 can be a glovebox that includes one or more, e.g., four, gloves 314 (ports 315 for the gloves are shown in Figure 3B).
- a front panel 316 of the isolator 310 can be transparent, e.g., formed of monolithic tempered glass, so that an operator can view the interior chamber of the isolator 310.
- the gloves 314 are positioned so that the operator can manipulate parts of the reactor system 400, e.g., to remove a reactor tube 410 containing coated particles after the deposition process from other portions of the reactor system 400, and to install a new reactor tube with uncoated particles for a subsequent deposition process.
- the isolator 310 can provide ISO 10648-2 Class-2 containment against leaks and/or containment for APIs up to OEB5 toxicity levels.
- the isolator 310 can include an air intake port 320 with an H14 HEPA filter to filter air entering the interior chamber 312, and an exhaust pump 322 connected to an air outlet port 324, also with an H14 HEPA filter.
- One or more outlet ports may return air to the environment around the isolator 310, or alternatively; the one or more outlet ports could be coupled directly to facility exhaust line for further processing.
- the exhaust pump operates to bring the interior chamber 312 to about -50 Pa to about -100 Pa relative to the surrounding pressure in the environment around the isolator 310.
- the isolator can be configured for aseptic operation at pressures slightly above atmospheric pressure, e.g., about 2%-20% above atmospheric pressure.
- a polished hygienic stainless steel filter housing can be used with a USP Class VI 0.2 pm exhaust filter.
- an oxidizer ampoule heater can heat water up to 135°C. for sterilization. Sterilization can follow refilling the ampoule, and periodically as needed.
- the isolator 310 also includes a rapid transfer port.
- the rapid transfer port includes a detachable transfer container 330 with an interior space 332.
- the transfer container can be sealed by a valve 334, and similarly the access port connecting the container 330 to the isolator 310 can be sealed by a valve 336.
- valves 334, 336 are open, the interior space 332 of the container 330 can be accessed by an operator using a glove 314.
- the reactor drum 410 could be placed into transfer container 330.
- coated particles could be transferred inside the isolator 310 from the reactor drum 410 into a canister 311 , and then the canister could be placed by the operator (using a glove 314) into the container 330.
- both valves 334, 336 are closed, the canister 130 can be manually detached from the isolator so that the contents can be transported to another location, e.g., for removal of coated particles from the drum, or for further processing of the particles such as mixture with excipients, pressing into a tablet, or encapsulation in a shell, without danger of contamination of the coated particles or the interior of the isolator 310.
- the interior 312 of the isolator 310 can also include a stand or platform 340 to support various components, e.g., parts of the reactor system 400 or tools used for assembly or disassembly of the reactor system 400 or for transfer of powder, within reach of the operator using a gloves 314.
- the canister 311 could be placed on the platform 340.
- some portions of the deposition system 300 can be located in a cleanroom 302.
- some other portions of the deposition system 300 e.g., a vacuum pump 250 for the reactor system 400 and an electrical cabinet 510 can be located in a technical area 304 at a much lower level of cleanliness than the cleanroom 302.
- the cleanroom 302 can be separated from the technical area by a partition wall 306.
- a controller 500 e.g., a programmed general purpose computer, can be located in the technical area 304 for the operator to control operation of the reactor system 400.
- the user interface for the controller 500 e.g., a touch screen display, keyboard
- the deposition system 300 also includes a heater assembly 520 to control the temperature of at least the reactor drum 410.
- the heater assembly 520 can include two half-cylindrical blocks, a lower half-cylindrical block 522 and an upper half-cylindrical block 324. Embedded in or placed on the surface of each cylindrical block 522 are one or more heating elements (e.g., a resistive heater with power supplied from the electrical cabinet 510).
- Each cylindrical block can be formed of a heat-sink material, e.g., anodized aluminum.
- the controller 500 is configured to operate the reactor system 400 in accord with a "recipe".
- the recipe specifies an operating value for each controllable element as a function of time.
- the recipe can specify the times during which the vacuum source 450 is to operate, the times of and flow rate for each gas source, the rotation rate of the rotary reaction drum 410 as set by the motor 442.
- the controller 500 can receive the recipe as computer-readable data (e.g., that is stored on a non-transitory computer readable medium).
- the reactor system 400 includes the rotatable reactor drum 410, a rotatable inlet tube 420, and a rotatable outlet tube 430.
- the rotatable inlet tube 420 and the rotatable outlet tube 430 are co-linear with the axis of rotation 412 of the rotatable reactor drum 410.
- the rotatable inlet tube 420 is fluidly coupled to a stationary inlet line 422 by an inlet rotary seal 424
- the rotatable outlet tube 430 is fluidly coupled to a stationary outlet line 432 by an outlet rotary seal 434.
- the rotary seals 424, 434 can reduce the risk of escape of particles from the reactor system 400.
- a labyrinth seal For the rotary seals 424, 434, one option would be to use a labyrinth seal.
- the circuitous path in a labyrinth seal can provide many opportunities for particles to adhere to a seal surface.
- a labyrinth seal may help maintain vacuum without need of external purge gas.
- a double cartridge mechanical seal can include a pair of bearings. In each bearing, an inner ring makes physical contact with an outer ring. Because the rings are in physical contact, the relative motion can result in wear, so the rings can be formed of a non-toxic material that will not interfere with the deposition process, e.g., graphite, or a ceramic with very low wear rate.
- a purge gas can be injected into the space between the pair of bearings to prevent atmospheric leakage into the reactor. For example, pressure of the purge gas can be controlled from less than 10 mTorr to about 30 psig to avoid N2 leakage into reactor and to prevent contamination from air.
- the rotatable outlet tube 430 can also function as a drive shaft for the rotatable reactor drum 410.
- a rotary drive system 440 includes a drive motor 442 to rotate the rotatable components, e.g., reactor drum 410, a rotatable inlet tube 420, and a rotatable outlet tube 430.
- a drive wheel 444 is fixed to the rotatable outlet tube 430 at a spot between the reactor drum 410 and the outlet rotary seal 434.
- the drive wheel 444 is coupled to the motor 442 by a drive belt 446.
- the rotary drive motor system 440 can rotate the reactor drum 410 at about 1 rpm to about 50 rpm, e.g., about 6 rpm to about 50 rpm.
- Motion of the reactor drum 410 can be clockwise (CW), counter-clockwise (CCW), or can alternate between CW and CCW.
- the deposition system 300 includes a vacuum source 450 (e.g., one or more vacuum pumps) coupled to the outlet line 432.
- the vacuum source 450 can be an industrial vacuum pump sufficient to establish pressures less than 1 Torr, e.g., about 1 mTorr to about 100 mTorr, e.g., about 20 mTorr to about 100 mTorr.
- the vacuum pump can establish a pressure less than 760 Torr, but at or greater than 1 Torr, e.g., about 1 Torr to about 100 Torr.
- the vacuum source 450 permits the interior 414 of the reactor drum 410 to be maintained at a desired pressure, and permits removal of reaction byproducts and unreacted process gases.
- a purge gas source 452 is connected to the outlet line 432, e.g., to create a back-pressure to remove powder blockage of the reactor drum end caps discussed below.
- the purge gas can be, for example, argon or nitrogen.
- One or more valves 454 can be used to control whether the vacuum source 450 or the purge gas source 452 is coupled to the outlet line 432.
- An ultra-low particulate air filter 458 can be plated in outlet line 432 between the vacuum source 450 and the outlet rotary seal 434 to prevent powder contamination downstream of the filter housing.
- the ultralow particulate air filter 458 can be a hygienic Parker demi stainless steel filter housing with a 0.2 pm TETPOR Air Filter Cartridge that meets USP Class VI standards.
- the housing can have additional polishing on the surfaces upstream of the filter to a 0.4 roughness (Ra) surface finish, and O-rings, e.g., USP Class VI Viton O-Rings, can be used for sealing of joints between parts.
- the upstream surfaces of the ultra-low particulate air filter 458 can be in contact with the API, so having surfaces that can be adequately cleaned can prevent biologic contamination.
- a chemical delivery system 460 includes multiple fluid sources coupled by respective delivery tubes and controllable valves to the inlet line 422.
- the chemical delivery system 460 injects the fluid in a vapor form into the reactor drum 410.
- the chemical delivery system 460 include a combination of restrictors, gas flow controllers, pressure transducers, and thermal mass flow controllers/meters to provide controllable flow rate of the various gasses into the reactor drum 410.
- the chemical delivery system 460 can also include one or more temperature control components (e.g., a heat exchanger, resistive heater) to heat or cool the various gasses before they flow into the reactor drum 410.
- an ampule cabinet 350 can be located adjacent the isolator 310.
- the ampule cabinet 350 includes a portion of the chemical delivery system 460 for the reactor system 400.
- located in the ampule cabinet 350 are one or more ports 462 configured to receive one or more ampules 333 or other precursor or gas sources containing precursors or purge gas (e.g., gas or liquid form) for the cyclic vapor coating processes described and discussed herein.
- the ports 4632 can be coupled by a manifold 464 that can include the various delivery tubes and controllable valves to control flow to the inlet line 422.
- the ampule cabinet 350 can include three or more ports 462 and three or more mass flow control (MFC) valves 455 - two MFC valves 455 for two metal precursors (one precursor per valve) and one MFC valve 455 for an oxidizing agent.
- the reagents and/or process gases can be, for example, a first metal precursor, a second metal precursor, an oxidizing agent, and one or more purge gases.
- a first metal precursor a second metal precursor
- an oxidizing agent an oxidizing agent
- purge gases for example, one or more aluminum precursors, one or more zinc precursors, water vapor, and a purge gas containing N2 and/or argon.
- Each of the MFC valves 455, 456 can independently contain an orifice having a diameter in a range from about 0.050 inches to about 0.150 inches, about 0.062 inches to about 0.113 inches, or about 0.075 inches to about 0.105 inches.
- the chemical delivery system 460 can include five fluid sources. Two of the fluid sources can provide the two chemically different precursors or reactants for the deposition process for forming a metal oxide coating or layer on the particles.
- the first fluid source can provide a first metal source, such as an aluminum precursor (e.g., trimethylaluminum (TMA)), to the first MFC valve 455, the second source can provide a purge gas (e.g., N2 and/or Ar) to the second MFC valve 455, and the third source can provide an oxidizing agent (e.g., water) to the third MFC valve 455.
- TMA trimethylaluminum
- the first fluid source can provide a first metal source, such as a zinc precursor (e.g., diethyl zinc (DEZ)), to the first MFC valve 455, the second source can provide a purge gas (e.g., N2 and/or Ar) to the second MFC valve 455, and the third source can provide an oxidizing agent (e.g., water) to the third MFC valve 455.
- a first metal source such as a zinc precursor (e.g., diethyl zinc (DEZ)
- DEZ diethyl zinc
- the second source can provide a purge gas (e.g., N2 and/or Ar) to the second MFC valve 455, and the third source can provide an oxidizing agent (e.g., water) to the third MFC valve 455.
- a purge gas e.g., N2 and/or Ar
- the first fluid source can provide a first metal precursor, an aluminum precursor (e.g., trimethylaluminum (TMA)), to the first MFC valve 455,
- the purge gas source 452 can provide a purge gas (e.g., N2 and/or Ar) to the MFC valve 456
- the second source can provide an oxidizing agent (e.g., water) to the second MFC valve 455
- the third source can provide a second metal precursor, such as a zinc precursor (e.g., diethyl zinc (DEZ)), to the third MFC valve 455.
- a second metal precursor such as a zinc precursor (e.g., diethyl zinc (DEZ)
- the mass flow of the chemistry to the reactor can sensed by a MFC valve 456, e.g., in the inlet line 432.
- the MFC valve 456 can send a signal indicating the mass flow rate to the controller 500, and the controller 500 can control the valves based on the received signal to establish a desired mass flow rate, thus providing a mass flow controller.
- the MFC valve 456 can be a thermal MFC. Such a thermal MFC senses changes in temperature in order to determine mass flow rate. Different materials have different calibration constants, e.g., different partial pressures as a function of temperature. The calibration constant needs to be programmed into the thermal MFC to properly convert a temperature measurement to a mass flow measurement. However, the calibration constant for TMA has been determined through empirical measurement and been found to be unexpectedly low, e.g., an Antoine vapor pressure ranging from about 9 Torr at about 20°C to about 16 Torr at about 30°C, which is about half that of water or DEZ. Due to the unusually low calibration constant, the mass flow controller itself may need to be customized, e.g., for orifice size and flow rate range. This can enable a high flow rate using a low vapor pressure source.
- the controller 500 and other computing devices part of systems described herein can be implemented in digital electronic circuitry, or in computer software, firmware, or hardware.
- the controller can include a processor to execute a computer program as stored in a computer program product, e.g., in a non-transitory machine readable storage medium.
- a computer program also known as a program, software, software application, or code
- Such a computer program can be written in any form of programming language, including compiled or interpreted languages, and it can be deployed in any form, including as a standalone program or as a module, component, subroutine, or other unit suitable for use in a computing environment.
- the controller 500 is a general purpose programmable computer.
- the controller can be implemented using special purpose logic circuitry, e.g., an FPGA (field programmable gate array) or an ASIC (application specific integrated circuit).
- a system of one or more computers to be configured to perform particular operations or actions means that the system has installed on it software, firmware, hardware, or a combination of them that in operation cause the system to perform the operations or actions.
- one or more computer programs to be configured to perform particular operations or actions means that the one or more programs include instructions that, when executed by data processing apparatus, cause the apparatus to perform the operations or actions.
- the present disclosure provides apparatus for and methods of preparing pharmaceutical compositions comprising API containing particles encapsulated by one or more layers of metal oxide and/or one or more layers of a polymer.
- the coating layers are conformal and of controlled thickness from several nanometers to several micrometers in total.
- the articles to be coated can be composed of only API or a combination of API and one or more excipients.
- the coating process described herein can provide an API with an increased glass transition temperature for the API relative to uncoated API, a decreased rate of crystallization for an amorphous form of the API relative to uncoated API, and decreased surface mobility of API molecules in the particle compared to uncoated API.
- particle dissolution can be altered.
- the coating is relatively thin, drug products with high drug loading can be achieved.
- a method of forming, producing, or otherwise preparing a coated powder composition includes positioning a plurality of powder particles within a processing region of a processing chamber, such as the deposition system 300, where each of the powder particles can be or contain an organic material, and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process.
- the metal oxide coating contains aluminum oxide, zinc oxide, or aluminum zinc oxide.
- the cyclic vapor coating process includes one, two, or more deposition cycles.
- the controller 500 is configured to and can be used to execute the following deposition cycles for the cyclic vapor coating process.
- Each of the deposition cycles includes introducing two or more pulses of a metal precursor (aluminum or zinc precursor) into the processing region via a first MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, exposing the plurality of powder particles to the metal precursor, and infiltrating the plurality of powder particles with the metal precursor via spaces between the powder particles.
- a metal precursor aluminum or zinc precursor
- each of the deposition cycles includes introducing two or more pulses of a purge gas (e.g., N2 or Ar) into the processing region via a second MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, and exposing the plurality of powder particles to the purge gas during a first purge process.
- a purge gas e.g., N2 or Ar
- each of the deposition cycles includes introducing two or more pulses of an oxidizing agent (e.g., water vapor) into the processing region via a third MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, exposing the plurality of powder particles to the oxidizing agent, and infiltrating the plurality of powder particles with the oxidizing agent via spaces between the powder particles to produce the metal oxide coating disposed on outer surfaces of each of the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a second purge process.
- a method of forming, producing, or otherwise preparing a coated powder composition includes positioning a plurality of powder particles within a processing region of a processing chamber, such as the deposition system 300, where each of the powder particles can be or contain an inorganic material, and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process.
- the metal oxide coating contains aluminum oxide, zinc oxide, or aluminum zinc oxide.
- the cyclic vapor coating process includes one, two, or more deposition cycles.
- the controller 500 is configured to and can be used to execute the following deposition cycles for the cyclic vapor coating process.
- Each of the deposition cycles includes introducing two or more pulses of a metal precursor into the processing region via a first MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, exposing the plurality of powder particles to the metal precursor, and infiltrating the plurality of powder particles with the metal precursor via spaces between the powder particles.
- each of the deposition cycles includes introducing two or more pulses of a purge gas into the processing region via a second MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, and exposing the plurality of powder particles to the purge gas during a first purge process.
- each of the deposition cycles includes introducing two or more pulses of an oxidizing agent into the processing region via a third MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, exposing the plurality of powder particles to the oxidizing agent, and infiltrating the plurality of powder particles with the oxidizing agent via spaces between the powder particles to produce the metal oxide coating disposed on outer surfaces of each of the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a second purge process.
- a method of forming, producing, or otherwise preparing a coated powder composition includes positioning a plurality of powder particles within a processing region of a processing chamber, such as the deposition system 300, and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process.
- the metal oxide coating contains aluminum zinc oxide.
- the cyclic vapor coating process includes one, two, or more deposition cycles.
- the controller 500 is configured to and can be used to execute the following deposition cycles for the cyclic vapor coating process.
- Each of the deposition cycles includes introducing two or more pulses of a first metal precursor (e.g., aluminum precursor) into the processing region via a first MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, exposing the plurality of powder particles to the first metal precursor, and infiltrating the plurality of powder particles with the first metal precursor via spaces between the powder particles.
- a first metal precursor e.g., aluminum precursor
- each of the deposition cycles includes introducing two or more pulses of a purge gas (e.g., N2 or Ar) into the processing region via a second MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, and exposing the plurality of powder particles to the purge gas during a first purge process.
- a purge gas e.g., N2 or Ar
- each of the deposition cycles includes introducing two or more pulses of an oxidizing agent (e.g., water vapor) into the processing region via a third MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, exposing the plurality of powder particles to the oxidizing agent, and infiltrating the plurality of powder particles with the oxidizing agent via spaces between the powder particles to produce a first metal oxide layer disposed on outer surfaces of each of the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a second purge process.
- each of the deposition cycles includes introducing two or more pulses of a second metal precursor (e.g., zinc precursor) into the processing region via a fourth MFC valve having an orifice with a diameter in a range from about 0.050 inches to about 0.150 inches, or from about 0.062 inches to about 0.113 inches, exposing the plurality of powder particles to the second metal precursor, and infiltrating the plurality of powder particles with the second metal precursor via spaces between the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas into the processing region via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a third purge process.
- each of the deposition cycles includes introducing two or more pulses of the oxidizing agent into the processing region via the third MFC valve, exposing the plurality of powder particles to the oxidizing agent, and infiltrating the plurality of powder particles with the oxidizing agent via spaces between the powder particles to produce a second metal oxide layer disposed on the first metal oxide layer disposed on the outer surfaces of each of the powder particles.
- each of the deposition cycles includes introducing two or more pulses of the purge gas via the second MFC valve, and exposing the plurality of powder particles to the purge gas during a fourth purge process.
- the first and second metal precursors are different from each other.
- the metal oxide coating contains the first metal oxide layer and the second metal oxide layer.
- the first metal oxide layer contains aluminum oxide
- the second metal oxide layer contains zinc oxide, or alternatively, the first metal oxide layer contains zinc oxide, then the second metal oxide layer contains aluminum oxide.
- the coated powder compositions are produced, fabricated, or otherwise prepared by the cyclic vapor coating processes 100, 200.
- Each of the coated particles of the coated powder composition has a core containing a powder particle and a metal oxide coating.
- the powder particle can be or include one or more organic materials or compounds, one or more inorganic materials or compounds, or any combination thereof.
- the powder particle comprises, consists, or consists essential of one or more organic materials or compounds, one or more inorganic materials or compounds, or any combination thereof.
- the metal oxide coating can be or include one or more aluminum oxide, zinc oxide, or aluminum zinc oxide.
- the metal oxide coating comprises, consists, or consists essential of aluminum oxide, zinc oxide, or aluminum zinc oxide.
- the plurality of coated particles can have an average particle size in a range from about 0.1 pm, about 0.2 pm, about 0.3 pm, about 0.5 pm, about 0.8 pm, about 1 pm, about 2 pm, about 3 pm, about 5 pm, about 8 pm, about 10 pm, about 12 pm, about 15 pm, about 18 pm, about 20 pm, about 25 pm, about 30 pm, or about 35 pm to about 40 pm, about 50 pm, about 60 pm, about 70 pm, about 80 pm, about 90 pm, about 100 pm, about 120 pm, about 150 pm, about 200 pm, about 300 pm, about 400 pm, about 500 pm, about 600 pm, about 700 pm, about 800 pm, about 900 pm, or about 1 ,000 pm.
- the plurality of coated particles can have an average particle size of about 0.1 pm to about 1 ,000 pm, about 0.1 pm to about 500 pm, about 0.1 pm to about 200 pm, about 0.1 pm to about 150 pm, about 0.1 pm to about 100 pm, about 0.1 pm to about 80 pm, about 0.1 pm to about 50 pm, about 0.1 pm to about 30 pm, about 0.1 pm to about 20 pm, about 0.1 pm to about 10 pm, about 0.1 pm to about 8 pm, about 0.1 pm to about 5 pm, about 0.1 pm to about 2 pm, about 0.1 pm to about 1 pm, about 0.1 pm to about 0.5 pm, about 1 pm to about 1 ,000 pm, about 1 pm to about 500 pm, about 1 pm to about 200 pm, about 1 pm to about 150 pm, about 1 pm to about 100 pm, about 1 pm to about 80 pm, about 1 pm to about 50 pm, about 1 pm to about 30 pm, about 1 pm to about 20 pm, about 1 pm to about 10 pm, about 1 pm to about 8 pm, about 1 pm to about 5 pm, about 0.1
- the plurality of coated particles can have an average particle size of about 1 pm to about 1 ,000 pm. In some examples, the plurality of coated particles can have an average particle size of about 1 pm to about 100 pm. In other examples, the plurality of coated particles can have an average particle size of about 1 pm to about 30 pm, or about 1 pm to about 10 pm.
- the metal oxide coating of each of the coated particles can have a thickness in a range from about 0.5 nm, about 1 nm, about 2 nm, about 3 nm, about 5 nm, about 8 nm, about 10 nm, about 12 nm, about 15 nm, about 18 nm, about 20 nm, about 25 nm, about 30 nm, or about 35 nm to about 40 nm, about 50 nm, about 60 nm, about 70 nm, about 80 nm, about 90 nm, about 100 nm, about 150 nm, about 200 nm, or greater.
- the metal oxide coating has a thickness of about 0.5 to about 200 nm, about 1 nm to about 100 nm, about 1 nm to about 95 nm, about 1 nm to about 90 nm, about 1 nm to about 80 nm, about 1 nm to about 70 nm, about
- the metal oxide coating of each of the coated particles has a thickness of about 0.5 nm to about 200 nm. In some examples, the metal oxide coating has a thickness of about 1 nm to about 100 nm. In other examples, the metal oxide coating has a thickness of about 10 nm to about 50 nm.
- the cyclic vapor coating process described and discussed herein provides low thermal budget and condensation free metal organic vapor flow; stable and reproducible mass flow on increasing chamber backpressure; accurate chemical consumption per pulse or per process run; reproducible chemical concentration treatments at low vapor pressures with other reactive chemical sources or oxidizers; and reproducible process to process chemical concentration control and mass flow verification.
- High surface area substrates such as API and other powder particles can be coated with metal oxide coatings to impart various bulk and particle-scale properties including but not limited to improved flowability and dissolution rates.
- Vapor phase metal oxide coating high surface area substrates is not trivial: vapor diffusion inhibition due to chamber geometry, variation in vapor species molecular sticking coefficients, variation in substrate surface morphology and functional groups, and total chamber pressure variation during processing can increase or decrease vapor condensation and chemical bonding on high surface area substrates at low pressure ( ⁇ 20 Torr) and low temperature ( ⁇ 25°C).
- Embodiments described and discussed herein provide methods to reproducibly deliver metal organic vapor to a processing chamber.
- Embodiments of the present disclosure further relate to any one or more of the following Examples 1 -31 :
- a method of forming a coated powder composition comprising: positioning a plurality of powder particles within a processing region of a processing chamber, wherein each of the powder particles comprises an organic material; and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process, wherein the metal oxide coating comprises aluminum oxide, zinc oxide, or aluminum zinc oxide, and wherein the cyclic vapor coating process comprises one or more deposition cycles, and each of the deposition cycles comprises: introducing two or more pulses of a metal precursor into the processing region via a first mass flow control valve; exposing the plurality of powder particles to the metal precursor; infiltrating the plurality of powder particles with the metal precursor via spaces between the powder particles; then introducing two or more pulses of a purge gas into the processing region via a second mass flow control valve; exposing the plurality of powder particles to the purge gas during a first purge process; then introducing two or more pulses of an oxidizing agent into the processing region
- a method of forming a coated powder composition comprising: positioning a plurality of powder particles within a processing region of a processing chamber, wherein each of the powder particles comprises an inorganic material; and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process, wherein the metal oxide coating comprises aluminum oxide, zinc oxide, or aluminum zinc oxide, and wherein the cyclic vapor coating process comprises one or more deposition cycles, and each of the deposition cycles comprises: introducing two or more pulses of a metal precursor into the processing region via a first mass flow control valve; exposing the plurality of powder particles to the metal precursor; infiltrating the plurality of powder particles with the metal precursor via spaces between the powder particles; then introducing two or more pulses of a purge gas into the processing region via a second mass flow control valve; exposing the plurality of powder particles to the purge gas during a first purge process; then introducing two or more pulses of an oxidizing agent into the
- a method of forming a coated powder composition comprising: positioning a plurality of powder particles within a processing region of a processing chamber; and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process, wherein the metal oxide coating comprises aluminum zinc oxide, and wherein the cyclic vapor coating process comprises one or more deposition cycles, and each of the deposition cycles comprises: introducing two or more pulses of a first metal precursor into the processing region via a first mass flow control valve; exposing the plurality of powder particles to the first metal precursor; infiltrating the plurality of powder particles with the first metal precursor via spaces between the powder particles; then introducing two or more pulses of a purge gas into the processing region via a second mass flow control valve; exposing the plurality of powder particles to the purge gas during a first purge process; then introducing two or more pulses of an oxidizing agent into the processing region via a third mass flow control valve; exposing the plurality of powder
- the first or second metal precursor comprises trimethyl aluminum, dimethyl aluminum hydride, triethyl aluminum, diethyl aluminum hydride, tripropyl aluminum, dipropyl aluminum hydride, tributyl aluminum, dibutyl aluminum hydride, isomers thereof, salts thereof, of any combination thereof.
- the first or second metal precursor comprises dimethyl zinc, diethyl zinc, dipropyl zinc, dibutyl zinc, isomers thereof, salts thereof, of any combination thereof.
- each of the powder particles comprises an organic material.
- each of the powder particles comprises an inorganic material.
- each of the pulses of the metal precursor is introduced into the processing region for about 30 seconds to about 60 seconds
- each of the pulses of the oxidizing agent is introduced into the processing region for about 30 seconds to about 60 seconds
- each of the pulses of the purge gas is introduced into the processing region for about 30 seconds to about 60 seconds.
- each of the deposition cycles comprises introducing from 3 pulses of the metal precursor to about 100 pulses of the metal precursor into the processing region; or wherein each of the deposition cycles comprises introducing from 5 pulses of the metal precursor to about 50 pulses of the metal precursor; or wherein each of the deposition cycles comprises introducing from 8 pulses of the metal precursor to about 35 pulses of the metal precursor.
- each of the deposition cycles comprises introducing from 3 pulses of the oxidizing agent to about 100 pulses of the oxidizing agent into the processing region; or wherein each of the deposition cycles comprises introducing from 5 pulses of the oxidizing agent to about 50 pulses of the oxidizing agent; or wherein each of the deposition cycles comprises introducing 8 pulses of the oxidizing agent to about 35 pulses of the oxidizing agent.
- each of the deposition cycles comprises introducing from 3 pulses of the purge gas to about 100 pulses of the purge gas into the processing region for each of the first and second purge processes; or wherein each of the deposition cycles comprises introducing from 5 pulses of the purge gas to about 50 pulses of the purge gas into the processing region for each of the first and second purge processes; or wherein each of the deposition cycles comprises introducing from 8 pulses of the purge gas to about 35 pulses of the purge gas into the processing region for each of the first and second purge processes.
- each of the metal precursor and the oxidizing agent is independently at a partial pressure of less than 2 Torr when being introduced into the processing region.
- each of the metal precursor and the oxidizing agent is independently introduced into the processing region having a stagnate atmosphere at a pressure of less than 760 Torr; or at a pressure from about 10 Torr to about 750 Torr.
- each of the orifices of the first, second, third, and fourth mass flow control valves independently has a diameter in a range from about 0.050 inches to about 0.150 inches, about or greater than 0.062 inches to about 0.113 inches, or about or greater than 0.062 inches to about 0.093 inches.
- the metal oxide coating consists essential of aluminum oxide, zinc oxide, or aluminum zinc oxide.
- the metal precursor comprises trimethyl aluminum, dimethyl aluminum hydride, triethyl aluminum, diethyl aluminum hydride, tripropyl aluminum, dipropyl aluminum hydride, tributyl aluminum, dibutyl aluminum hydride, isomers thereof, salts thereof, of any combination thereof.
- oxidizing agent comprises water, oxygen (O2), hydrogen peroxide, inorganic peroxide, ozone, atomic oxygen, oxygen plasma, or any combination thereof.
- a method of forming a coated powder composition comprising: positioning a plurality of powder particles within a processing region of a processing chamber, wherein each of the powder particles comprises active pharmaceutical ingredients (APIs); and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process, wherein the metal oxide coating comprises aluminum oxide or zinc oxide, and wherein the cyclic vapor coating process comprises one or more deposition cycles, and each of the deposition cycles comprises: introducing a pulse of a metal precursor into the processing region via a first mass flow control valve having an orifice with a diameter greater than 0.062 inches to about 0.113 inches; exposing the plurality of powder particles to the metal precursor; infiltrating the plurality of powder particles with the metal precursor via spaces between the powder particles; then introducing a pulse of a purge gas into the processing region via a second mass flow control valve; exposing the plurality of powder particles to the purge gas during a first purge process; then
- a method of forming a coated powder composition comprising: positioning a plurality of powder particles within a processing region of a processing chamber, wherein each of the powder particles comprises active pharmaceutical ingredients (APIs), wherein the plurality of powder particles are maintained at a temperature in a range from about 15°C to about 25°C during the cyclic vapor coating process; and coating the plurality of powder particles with a metal oxide coating to form a plurality of coated particles during a cyclic vapor coating process, wherein the metal oxide coating comprises aluminum oxide, and wherein the cyclic vapor coating process comprises one or more deposition cycles, and each of the deposition cycles comprises: introducing a pulse of a metal precursor into the processing region via a first mass flow control valve having an orifice with a diameter greater than 0.062 inches to about 0.113 inches, wherein the metal precursor is at a temperature of about -20°C to about 20°C and at a pressure of about 0.01 Torr to about 20 Torr when being introduced into the first mass flow control valve
- a coated powder composition made, produced, fabricated, made, or formed by the method according to any one of examples 1 -30.
- compositions, an element, or a group of elements are preceded with the transitional phrase “comprising”, it is understood that the same composition or group of elements with transitional phrases “consisting essentially of”, “consisting of”, “selected from the group of consisting of”, or “is” preceding the recitation of the composition, element, or elements and vice versa, are contemplated.
- the term “about” refers to a +/-10% variation from the nominal value. It is to be understood that such a variation can be included in any value provided herein.
Landscapes
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Mechanical Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Vapour Deposition (AREA)
Abstract
Des modes de réalisation de la présente divulgation concernent de manière générale des procédés de revêtement par vapeur pour préparer des compositions de poudre revêtues. Dans un ou plusieurs modes de réalisation, un procédé de préparation d'une composition de poudre revêtue est fourni et comprend le positionnement d'une pluralité de particules de poudre à l'intérieur d'une région de traitement, chacune des particules de poudre contenant un ou plusieurs matériaux organiques, un ou plusieurs matériaux inorganiques, ou des combinaisons de ceux-ci, et le revêtement de la pluralité de particules de poudre avec un revêtement d'oxyde métallique pour former une pluralité de particules revêtues pendant un procédé de revêtement par vapeur cyclique. Le revêtement d'oxyde métallique contient de l'oxyde d'aluminium, de l'oxyde de zinc ou de l'oxyde d'aluminium-zinc, et le procédé de revêtement par vapeur cyclique comprend un ou plusieurs cycles de dépôt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263420291P | 2022-10-28 | 2022-10-28 | |
US63/420,291 | 2022-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024091652A1 true WO2024091652A1 (fr) | 2024-05-02 |
Family
ID=90831802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/036104 WO2024091652A1 (fr) | 2022-10-28 | 2023-10-27 | Procédés de préparation de compositions de poudre revêtues |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024091652A1 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040099719A (ko) * | 2003-05-20 | 2004-12-02 | 한국에너지기술연구원 | 금속 및 금속화합물의 입자 코팅을 위한 유동층화학기상증착 방법 및 그 장치 |
KR20150008667A (ko) * | 2013-07-15 | 2015-01-23 | 광주과학기술원 | 나노코팅 입자 제조를 위한 유동층 원자층 증착 장치 |
US20190376182A1 (en) * | 2018-06-12 | 2019-12-12 | Colin C. Neikirk | Rotary reactor for uniform particle coating with thin films |
US20200335311A1 (en) * | 2019-04-22 | 2020-10-22 | Board Of Trustees Of Michigan State University | Rotary plasma reactor |
US20200338008A1 (en) * | 2019-04-26 | 2020-10-29 | Applied Materials, Inc. | Coated Drug Compositions and Methods of Preparing the Same |
US20210121415A1 (en) * | 2013-05-24 | 2021-04-29 | Nanexa Ab | Solid nanoparticle with inorganic coating |
-
2023
- 2023-10-27 WO PCT/US2023/036104 patent/WO2024091652A1/fr unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040099719A (ko) * | 2003-05-20 | 2004-12-02 | 한국에너지기술연구원 | 금속 및 금속화합물의 입자 코팅을 위한 유동층화학기상증착 방법 및 그 장치 |
US20210121415A1 (en) * | 2013-05-24 | 2021-04-29 | Nanexa Ab | Solid nanoparticle with inorganic coating |
KR20150008667A (ko) * | 2013-07-15 | 2015-01-23 | 광주과학기술원 | 나노코팅 입자 제조를 위한 유동층 원자층 증착 장치 |
US20190376182A1 (en) * | 2018-06-12 | 2019-12-12 | Colin C. Neikirk | Rotary reactor for uniform particle coating with thin films |
US20200335311A1 (en) * | 2019-04-22 | 2020-10-22 | Board Of Trustees Of Michigan State University | Rotary plasma reactor |
US20200338008A1 (en) * | 2019-04-26 | 2020-10-29 | Applied Materials, Inc. | Coated Drug Compositions and Methods of Preparing the Same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11180851B2 (en) | Rotary reactor for uniform particle coating with thin films | |
US11242599B2 (en) | Particle coating methods and apparatus | |
US11717800B2 (en) | Reactor for coating particles in stationary chamber with rotating paddles | |
US20230355536A1 (en) | Ozone-based low temperature silicon oxide coating for pharmaceutical applications | |
US12071685B2 (en) | Gas injection for de-agglomeration in particle coating reactor | |
US20220105048A1 (en) | Low Temperature Process For Preparing Silicon Oxide Coated Pharmaceuticals | |
WO2024091652A1 (fr) | Procédés de préparation de compositions de poudre revêtues | |
US20230097519A1 (en) | Low temperature silicon oxide coating for pharmaceutical applications | |
US20230128094A1 (en) | Rotary reactor with drum for deposition of films onto particles | |
TWI852104B (zh) | 用於製藥應用之低溫氧化矽塗層 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23883470 Country of ref document: EP Kind code of ref document: A1 |